The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

PARIS (Reuters) - France's top health body will on Friday say that recipients of a first dose of AstraZeneca's traditional COVID-19 vaccine who are under 55 should get a second shot with a new-style ...

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next year, with key trial readouts expected from companies including Moderna ...

The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...

Australia currently produces AstraZeneca's coronavirus vaccines in the country but earlier this month restricted its rollout to people above 50 years. Merlino said he is liaising with the federal ...

Daiichi Sankyo and AstraZeneca have pressed swiftly to file for approval of their TROP2-targeting drug Datroway for ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...